QOL Medical, LLC is a patient-centric company focused on acquisition/commercialization of orphan therapies in underserved markets. QOL ensures expanded clinical awareness and patient access for improved quality of life in treatment of orphan diseases. QOL currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (Ethanolamine Oleate) Injection 5%.
Brands: Sucraid® (sacrosidase) Oral Solution
Ethamolin® (Ethanolamine Oleate) Injection 5%
DDW Tracks Microbiome in Gastrointestinal and Liver Diseases, Inflammatory Bowel Diseases, Liver Diseases and Transplantation, Esophageal Diseases, Stomach and Small Bowel Disorders, Colorectal Diseases, Functional GI and Motility Disorders, Pancreatic Diseases, Biliary Tract Diseases
Does your company only service US attendees? No